HPC
HM Payson & Co’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-50
| Closed | -$1K | – | 1174 |
|
|
2021
Q1 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1107 |
|
|
2019
Q4 | – | Sell |
-750
| Closed | -$5K | – | 970 |
|
|
2019
Q3 | $5K | Hold |
750
| – | – | ﹤0.01% | 878 |
|
|
2019
Q2 | $7K | Buy |
+750
| New | +$7K | ﹤0.01% | 857 |
|
|
2017
Q3 | – | Sell |
-33,764
| Closed | -$1.12M | – | 345 |
|
|
2017
Q2 | $1.12M | Sell |
33,764
-13,586
| -29% | -$451K | 0.05% | 178 |
|
|
2017
Q1 | $1.52M | Sell |
47,350
-5,049
| -10% | -$162K | 0.07% | 159 |
|
|
2016
Q4 | $1.9M | Sell |
52,399
-14,809
| -22% | -$537K | 0.09% | 140 |
|
|
2016
Q3 | $3.09M | Sell |
67,208
-1,656
| -2% | -$76.2K | 0.15% | 113 |
|
|
2016
Q2 | $3.46M | Sell |
68,864
-3,991
| -5% | -$200K | 0.17% | 100 |
|
|
2016
Q1 | $3.9M | Sell |
72,855
-9,582
| -12% | -$513K | 0.2% | 97 |
|
|
2015
Q4 | $5.41M | Buy |
82,437
+1,488
| +2% | +$97.7K | 0.28% | 84 |
|
|
2015
Q3 | $4.57M | Sell |
80,949
-9,475
| -10% | -$535K | 0.25% | 92 |
|
|
2015
Q2 | $5.34M | Sell |
90,424
-17,661
| -16% | -$1.04M | 0.27% | 88 |
|
|
2015
Q1 | $6.73M | Sell |
108,085
-97,239
| -47% | -$6.06M | 0.34% | 77 |
|
|
2014
Q4 | $11.8M | Sell |
205,324
-9,988
| -5% | -$574K | 0.58% | 52 |
|
|
2014
Q3 | $11.6M | Sell |
215,312
-4,387
| -2% | -$236K | 0.59% | 50 |
|
|
2014
Q2 | $11.5M | Sell |
219,699
-105,269
| -32% | -$5.52M | 0.59% | 52 |
|
|
2014
Q1 | $17.2M | Sell |
324,968
-65,547
| -17% | -$3.46M | 0.91% | 38 |
|
|
2013
Q4 | $15.7M | Buy |
390,515
+9,456
| +2% | +$379K | 0.84% | 37 |
|
|
2013
Q3 | $14.4M | Buy |
381,059
+23,980
| +7% | +$906K | 0.83% | 40 |
|
|
2013
Q2 | $14M | Buy |
+357,079
| New | +$14M | 0.84% | 40 |
|